Skip to main content
All lobbying clients

PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

Lobbying client · District of Columbia · filed 2025 to 2026

$1,610,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (115000), not by name.

 Firms hired 1
 Bills named in these filings 30
  • S 1414
    Expedited Access to Biosimilars Act
    5 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    4 filings
  • S 1954
    Biosimilar Red Tape Elimination Act
    4 filings
  • HR 5526
    Biosimilar Red Tape Elimination Act
    3 filings
  • S 1095
    Stop STALLING Act
    3 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    3 filings
  • S 43
    Skinny Labels, Big Savings Act
    3 filings
  • S 1040
    A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Vete…
    2 filings
  • S 5459
    Biosimilars Access and Affordability Act
    2 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    2 filings
  • HR 2821
    FDA Modernization Act 3.0
    2 filings
  • HR 6485
    Skinny Labels, Big Savings Act
    2 filings
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
    2 filings
  • S 2658
    Medication Affordability and Patent Integrity Act
    2 filings
  • S 355
    FDA Modernization Act 3.0
    2 filings
  • S 832
    EPIC Act of 2025
    2 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    1 filing
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    1 filing
  • HR 1843
    To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
    1 filing
  • HR 2715
    Destruction of Hazardous Imports Act
    1 filing
  • HR 3269
    ETHIC Act
    1 filing
  • HR 3701
    Family Vaccine Protection Act
    1 filing
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    1 filing
  • HR 7140
    CLEAR Act
    1 filing
  • HR 7953
    FAIR ACT
    1 filing
  • HR 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
    1 filing
  • HR 946
    ORPHAN Cures Act
    1 filing
  • S 1040
    Drug Competition Enhancement Act
    1 filing
  • S 1041
    Affordable Prescriptions for Patients Act
    1 filing
  • S 1071
    National Defense Authorization Act for Fiscal Year 2026
    1 filing
 Reported by year 2 years
  • 2026 $670,000 2 filings
  • 2025 $940,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 1
  • SENATE 3

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem